Paper24459652
Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.
Park HJ and 4 others. World J Mens Health, 2013. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil. Papers, record 24459652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24459652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References75
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18281145 | A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. | Eur Urol | 2008 | https://conductscience.org/library/papers/18281145 | PubMed |
| 2 | 22704110 | Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men. | J Urol | 2012 | https://conductscience.org/library/papers/22704110 | PubMed |
| 3 | 21284024 | Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. | Neurourol Urodyn | 2011 | https://conductscience.org/library/papers/21284024 | PubMed |
| 4 | 16387575 | Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). | Am J Cardiol | 2005 | https://conductscience.org/library/papers/16387575 | PubMed |
| 5 | 21502967 | National-wide data on the treatment of BPH in Korea. | Prostate Cancer Prostatic Dis | 2011 | https://conductscience.org/library/papers/21502967 | PubMed |
| 6 | 12509363 | Prevalence of three lower urinary tract symptoms in men-a population-based study. | Fam Pract | 2003 | https://conductscience.org/library/papers/12509363 | PubMed |
| 7 | 11750246 | Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. | Urology | 2001 | https://conductscience.org/library/papers/11750246 | PubMed |
| 8 | 21812935 | Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats. | J Sex Med | 2011 | https://conductscience.org/library/papers/21812935 | PubMed |
| 9 | 23596600 | Prevalence of Benign Prostatic Hyperplasia on Jeju Island: Analysis from a Cross-sectional Community-based Survey. | World J Mens Health | 2012 | https://conductscience.org/library/papers/23596600 | PubMed |
| 10 | 7718025 | Reduced smooth muscle cell regeneration in Yoshida (YOS) spontaneously hypercholesterolemic rats. | Atherosclerosis | 1994 | https://conductscience.org/library/papers/7718025 | PubMed |
| 11 | 21871706 | Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial. | Eur Urol | 2011 | https://conductscience.org/library/papers/21871706 | PubMed |
| 12 | 16613526 | BPH: epidemiology and comorbidities. | Am J Manag Care | 2006 | https://conductscience.org/library/papers/16613526 | PubMed |
| 13 | 17138653 | Characterization and functional role of androgen-dependent PDE5 activity in the bladder. | Endocrinology | 2007 | https://conductscience.org/library/papers/17138653 | PubMed |
| 14 | 18005205 | An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. | BJU Int | 2008 | https://conductscience.org/library/papers/18005205 | PubMed |
| 15 | 22759598 | Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck. | J Sex Med | 2012 | https://conductscience.org/library/papers/22759598 | PubMed |
| 16 | 11696815 | Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. | J Urol | 2001 | https://conductscience.org/library/papers/11696815 | PubMed |
| 17 | 12853851 | Chronic ischemia increases prostatic smooth muscle contraction in the rabbit. | J Urol | 2003 | https://conductscience.org/library/papers/12853851 | PubMed |
| 18 | 21475707 | Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. | Curr Bladder Dysfunct Rep | 2010 | https://conductscience.org/library/papers/21475707 | PubMed |
| 19 | 15091043 | Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents? | Curr Opin Urol | 2004 | https://conductscience.org/library/papers/15091043 | PubMed |
| 20 | 21420124 | Update on AUA guideline on the management of benign prostatic hyperplasia. | J Urol | 2011 | https://conductscience.org/library/papers/21420124 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42621383 | Bladder multilithiasis across different clinical scenarios: Multimodality imaging findings, differential diagnosis, and complication assessment in 4 patients. | Radiol Case Rep | 2026 | https://conductscience.org/library/papers/42621383 | PubMed |
| 42488927 | Fucoidan from Undaria pinnatifida Improves Benign Prostatic Hyperplasia Symptoms in Men: A Randomized, Double-Blind, Placebo-Controlled Study. | Res Rep Urol | 2026 | https://conductscience.org/library/papers/42488927 | PubMed |
| 42075556 | The Role of the Aging Bladder in Lower Urinary Tract Symptoms: Pathophysiology and Therapeutic Implications in Patients with Benign Prostatic Hyperplasia. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42075556 | PubMed |
| 42021565 | Rates and Predictors of Persistent LUTS Medication Use After Laser Enucleation of the Prostate. | Low Urin Tract Symptoms | 2026 | https://conductscience.org/library/papers/42021565 | PubMed |
| 41809799 | Phosphodiesterase inhibitors for the management of lower urinary tract symptoms in men without benign prostatic hyperplasia: a systematic review. | Transl Androl Urol | 2026 | https://conductscience.org/library/papers/41809799 | PubMed |
| 41726851 | Evaluation of the Transition from Holmium:YAG to Pulsed Thulium:YAG for Laser Endoscopic Enucleation of the Prostate and the Effect on Procedural Performance. | Eur Urol Open Sci | 2026 | https://conductscience.org/library/papers/41726851 | PubMed |
| 41608110 | Modern approaches to BPH management: expert insights and the latest evidence from the 2024 International Functional and Reconstructive Urology Update. | Ther Adv Urol | 2026 | https://conductscience.org/library/papers/41608110 | PubMed |
| 41472933 | Postoperative tadalafil for recovery of continence and voiding function after radical prostatectomy for prostate cancer: a single-center experience. | Prostate Int | 2025 | https://conductscience.org/library/papers/41472933 | PubMed |
| 41350372 | Predictors and predictive performance of immune-inflammation indices for symptom severity in benign prostatic hyperplasia. | Sci Rep | 2025 | https://conductscience.org/library/papers/41350372 | PubMed |
| 41304774 | Comprehensive Analytical Studies on the Solubility and Dissolution Rate Enhancement of Tadalafil with Type IV Lipid Formulations. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41304774 | PubMed |
| 41047361 | Comparative Trends in the Treatment of Male Lower Urinary Tract Symptoms in South Korea and the United States of America (USA) Based on Korean National Health Insurance Data. | World J Mens Health | 2026 | https://conductscience.org/library/papers/41047361 | PubMed |
| 40759594 | Efficacy and Safety of Mirabegron and Tamsulosin Combination Therapy Compared to Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Results of a Multicenter, Randomized, Double-Blind, Phase III Clinical Trial. | World J Mens Health | 2026 | https://conductscience.org/library/papers/40759594 | PubMed |
| 39872316 | A comprehensive analysis of erectile dysfunction prevalence and the impact of prostate conditions on ED among US adults: evidence from NHANES 2001-2004. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39872316 | PubMed |
| 39725984 | Prostatectomy outcomes for patients with benign prostatic hyperplasia and its associated factors in East and West Gojjam zones comprehensive specialized hospitals, Northwest Ethiopia. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/39725984 | PubMed |
| 39649919 | Prevalence of bacteriuria and treatment outcomes in patients with symptomatic benign prostatic hyperplasia: a prospective observational study. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/39649919 | PubMed |
| 37745908 | Changes of resistance indices after medication in benign prostatic hyperplasia: a prospective study. | Prostate Int | 2023 | https://conductscience.org/library/papers/37745908 | PubMed |
| 37006221 | Evaluation of intermittent tamsulosin in treating symptomatic patients with benign prostatic hyperplasia. | Urol Ann | 2023 | https://conductscience.org/library/papers/37006221 | PubMed |
| 36792092 | The Need for Prospective Cohort Study of the Association between Lower Urinary Tract Symptoms and Cognitive Decline in Elderly Individuals. | World J Mens Health | 2023 | https://conductscience.org/library/papers/36792092 | PubMed |
| 36629062 | Quisqualis indica extract for men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled trial. | Investig Clin Urol | 2023 | https://conductscience.org/library/papers/36629062 | PubMed |
| 36086750 | Factors associated with quality of life in patients with benign prostatic hyperplasia, 2009-2016. | Medicine (Baltimore) | 2022 | https://conductscience.org/library/papers/36086750 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 | NCBI Gene |
| PDE5A | 8654 | PubTator's text mining | https://conductscience.org/library/genes/8654 | NCBI Gene |
| RHOA | 387 | PubTator's text mining | https://conductscience.org/library/genes/387 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24459652
GET https://conductscience.org/api/papers/v1/24459652/references?page=2